Low concentration arsenite activated JAK2/STAT3 signal and increased proliferative factor expressions in SV-HUC-1cells after short and long time treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low concentration arsenite activated JAK2/STAT3 signal and increased proliferative factor expressions in SV-HUC-1cells after short and long time treatment
Authors
Keywords
-
Journal
ENVIRONMENTAL TOXICOLOGY
Volume 32, Issue 9, Pages 2154-2162
Publisher
Wiley
Online
2017-04-26
DOI
10.1002/tox.22428
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer
- (2016) Hyun-Jeong Ko et al. ARCHIVES OF PHARMACAL RESEARCH
- Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells
- (2015) Jin Mo Ku et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Chronic inorganic arsenic exposure in vitro induces a cancer cell phenotype in human peripheral lung epithelial cells
- (2015) Rachel J. Person et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Inflammatory cytokine COX-2 mediated cell proliferation through increasing cyclin D1 expression induced by inorganic arsenic in SV-HUC-1 human uroepithelial cells
- (2015) Wang Fei et al. Toxicology Research
- Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation
- (2014) Jiaying Sun et al. CANCER LETTERS
- JAK2, STAT3 and SOCS3 gene expression in women with and without breast cancer
- (2014) Jonnathan Guadalupe Santillán-Benítez et al. GENE
- Reactive oxygen species contribute to arsenic-induced EZH2 phosphorylation in human bronchial epithelial cells and lung cancer cells
- (2014) Lingzhi Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The acquisition of cancer stem cell-like properties and neoplastic transformation of human keratinocytes induced by arsenite involves epigenetic silencing of let-7c via Ras/NF-κB
- (2014) Rongrong Jiang et al. TOXICOLOGY LETTERS
- Drinking Water Arsenic in Northern Chile: High Cancer Risks 40 Years after Exposure Cessation
- (2013) C. M. Steinmaus et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/β-Catenin Signaling Pathway
- (2013) Deepak Bhatia et al. Evidence-based Complementary and Alternative Medicine
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic
- (2012) Bailing Chen et al. CELL CYCLE
- Arsenic Exposure and Cardiovascular Disease:An Updated Systematic Review
- (2012) Katherine Moon et al. Current Atherosclerosis Reports
- JNK-Dependent Stat3 Phosphorylation Contributes to Akt Activation in Response to Arsenic Exposure
- (2012) J. Liu et al. TOXICOLOGICAL SCIENCES
- Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
- (2009) Bharat B. Aggarwal et al. Annals of the New York Academy of Sciences
- STAT3 as a Central Regulator of Tumor Metastases
- (2009) Eswaran Devarajan et al. CURRENT MOLECULAR MEDICINE
- Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival
- (2008) Chun-Liang Chen et al. Molecular Cancer
- Reactive oxygen species regulate properties of transformation in UROtsa cells exposed to monomethylarsonous acid by modulating MAPK signaling
- (2008) K.E. Eblin et al. TOXICOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started